tiprankstipranks
Trending News
More News >
Sionna Therapeutics, Inc. (SION)
NASDAQ:SION
US Market

Sionna Therapeutics, Inc. (SION) Income Statement

Compare
23 Followers

Sionna Therapeutics, Inc. Income Statement

Last quarter (Q3 2025), Sionna Therapeutics, Inc.'s total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Sionna Therapeutics, Inc.'s net income was $-20.28M. See Sionna Therapeutics, Inc.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22
Total Revenue
$ 0.00$ 0.00$ 0.00
Gross Profit
$ -668.00K$ 0.00$ 0.00
Operating Expenses
$ 69.89M$ 50.33M$ 41.37M
Depreciation and Amortization
$ 668.00K$ 583.00K$ 122.00K
EBITDA
$ -69.89M$ -49.75M$ -41.25M
Operating Income
$ -70.56M$ -50.33M$ -41.37M
Other Income/Expenses
$ 8.87M$ 3.07M$ 1.13M
Pretax Income
$ -61.69M$ -47.26M$ -40.24M
Net Income
$ -61.69M$ -47.26M$ -40.24M
Per Share Metrics
Basic EPS
$ -1.40$ -1.07$ -0.91
Diluted EPS
$ -1.40$ -1.07$ -0.91
Weighted Average Shares Outstanding
44.12M 44.12M 44.12M
Weighted Average Shares Outstanding (Diluted)
44.12M 44.12M 44.12M
Currency in USD

Sionna Therapeutics, Inc. Earnings and Revenue History